SNIFFPHONE (Horizon 2020 Framework Program) project carried out by an international consortium of scientific institutions and companies (also a member was LU KPMI) - "Smart Phone for Disease Detection from Exhaled Breath", in which the clinical work was organized and conducted by researchers of the Institute of Clinical and Preventive Medicine was carried out 15.02.2015. – 15.08.2018.

The SNIFFPHONE project has developed a cellular-compatible sensor respiratory analyzer for detecting diseases - a portable "electronic nose" capable of accurately identifying gastric cancer after a patient's exhalation. The device has a very wide potential application and can be transferred to other disease detection and monitoring.

Sniffphone developers are engineers and scientists from Israel, Germany, Ireland, Austria and Finland.

The University of Latvia has been a major clinical partner in this major project to develop new disease screening techniques using artificial nose technology.
LU KPMI project implemented device testing in clinical settings, analytics, patient involvement, sensor data analysis.

The project was led by professor Hossam Haick from the Israeli Technion Institute.
The head of the clinical team of the project is M.Leja, Director of the LU KPMI.

The SNIFFPHONE project has also received the European Commission Innovation Award in the Innovative Project category. The award was presented on November 21, 2018 in Lisbon, Portugal, at the European Forum on Electronic Components and Systems.

Researchers of the Institute are continuing their research in this area in the framework of several other projects.

The video produced jointly by the SNIFFPHONE project partners is available HERE.

 

The SNIFFPHONE project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement no. 644031

Dalīties